Xoma NASDAQ: XOMA www.xoma.com
1 known investors
XOMA Royalty acquires and manages royalty interests in commercial and development-stage therapeutics, operating as a biotech-focused royalty aggregator. The company provides funding and structured finance to biopharmaceutical and medical technology firms.
BiotechFintech
Founders & leadership
OH
Owen HughesChief Executive Officer
JT
Jeffrey TrigilioChief Financial Officer
BS
Brad SitkoChief Investment Officer
MM
Maricel MontanoChief Legal Officer
Investors · 1
Competitors · 2
by search overlapRobinhood85 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Bioworld68 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Companies competing with Xoma NASDAQ: XOMA www.xoma.com for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Xoma NASDAQ: XOMA www.xoma.com do?
- XOMA Royalty acquires and manages royalty interests in commercial and development-stage therapeutics, operating as a biotech-focused royalty aggregator. The company provides funding and structured finance to biopharmaceutical and medical technology firms.
- Who are Xoma NASDAQ: XOMA www.xoma.com's investors?
- Xoma NASDAQ: XOMA www.xoma.com's investors include Sanderling Ventures.